Skip to main content
Clinical Trials/NCT07006896
NCT07006896Active, not recruitingNot Applicable

Labor Induction After Cesarean: A Randomized Trial Of Cervical Balloon With or Without Oxytocin

University of Pennsylvania2 sites in 1 country100 target enrollmentStarted: July 10, 2025Last updated:
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Enrollment
100
Locations
2
Primary Endpoint
Time to delivery

Study Overview

Brief Summary

A randomized trial of patients undergoing a term (≥37 weeks) induction of labor with a history of one prior Cesarean delivery, wherein the provider intends to use a Foley catheter for cervical ripening. The investigators will be comparing Foley alone with concurrent Foley and Oxytocin use at the start of the induction. With this trial, the investigators aim to test our central hypothesis that concurrent Foley and Oxytocin will decrease time to delivery without increasing risks, compared to Foley alone.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Eligible for induction of labor
  • Live singleton gestation ≥37 weeks
  • History of 1 cesarean delivery
  • ≥18 years of age
  • Cephalic presentation
  • Intact membranes
  • English or Spanish speaking (Able to read/understand consent and instructions)
  • Cervical dilation <3cm and Bishop score <8

Exclusion Criteria

  • >1 prior Cesarean delivery
  • Known chorioamnionitis
  • Major fetal anomaly

Arms & Interventions

Foley balloon alone

Active Comparator

Cervical ripening will begin with a Foley balloon alone. Oxytocin will not be started until the balloon is removed or expelled, though can be considered if the balloon remains in place for >8 hours

Intervention: Foley balloon (Device)

Concurrent Foley balloon and Oxytocin

Experimental

Cervical ripening will begin with a Foley balloon and concurrent oxytocin, started within 2 hour of balloon placement

Intervention: Foley balloon (Device)

Concurrent Foley balloon and Oxytocin

Experimental

Cervical ripening will begin with a Foley balloon and concurrent oxytocin, started within 2 hour of balloon placement

Intervention: Oxytocin (Drug)

Outcomes

Primary Outcomes

Time to delivery

Time Frame: At delivery

The primary endpoint will be time from start of induction until delivery (hours)

Secondary Outcomes

  • Number of Participants with Uterine Rupture(At delivery)
  • Estimated postpartum blood loss(At delivery)
  • Postpartum hemorrhage(Within 6 weeks of delivery)
  • Number of Participants with Chorioamnionitis(At delivery)
  • Mode of delivery(At delivery)
  • Maternal morbidity(Within 6 weeks of delivery)
  • Neonatal morbidity(Within 6 weeks of delivery)
  • Maternal length of stay(From date of delivery to date of discharge from hospital postpartum, up to 6 weeks from delivery)
  • Neonatal length of stay(From date of delivery to date of discharge from hospital postpartum, up to 6 weeks from delivery)
  • NICU stay greater than 48 hours(From date of delivery to date of discharge from hospital postpartum, up to 6 weeks from delivery)
  • Maternal patient satisfaction as measured by the Hollins Martin Birth Satisfaction scale-Revised (BSS-R)(From time of delivery to discharge from hospital, up to 6 weeks from delivery)
  • Mode of delivery(At delivery)
  • Estimated postpartum blood loss(At delivery)
  • Postpartum hemorrhage(Within 6 weeks of delivery)
  • Maternal morbidity(Within 6 weeks of delivery)
  • Neonatal morbidity(Within 6 weeks of delivery)
  • Maternal length of stay(From date of delivery to date of discharge from hospital postpartum, up to 6 weeks from delivery)
  • Neonatal length of stay(From date of delivery to date of discharge from hospital postpartum, up to 6 weeks from delivery)
  • NICU stay greater than 48 hours(From date of delivery to date of discharge from hospital postpartum, up to 6 weeks from delivery)
  • Maternal patient satisfaction as measured by the Hollins Martin Birth Satisfaction scale-Revised (BSS-R)(From time of delivery to discharge from hospital, up to 6 weeks from delivery)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Lisa Levine

Associate Professor

University of Pennsylvania

Study Sites (2)

Loading locations...

Similar Trials